Citation Impact
Citing Papers
Adenosine 2B Receptor Expression on Cancer Cells Promotes Metastasis
2016
The MET Receptor Tyrosine Kinase Is a Potential Novel Therapeutic Target for Head and Neck Squamous Cell Carcinoma
2009
CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment
2018
The 2.6 Angstrom Crystal Structure of a Human A 2A Adenosine Receptor Bound to an Antagonist
2008 StandoutScience
A Novel Antagonist of the Immune Checkpoint Protein Adenosine A2a Receptor Restores Tumor-Infiltrating Lymphocyte Activity in the Context of the Tumor Microenvironment
2017
Head and neck squamous cell carcinoma
2020 Standout
Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects
2020
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Myeloid-derived suppressor cells coming of age
2018 Standout
Anti-CD73 in Cancer Immunotherapy: Awakening New Opportunities
2016
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer
2018
Persistent kallikrein 5 activation induces atopic dermatitis-like skin architecture independent of PAR2 activity
2017 StandoutNobel
A role for phosphoinositol 3–kinase δ in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease
2010
NF-κB signaling in inflammation
2017 Standout
Adenosine Receptors in Health and Disease
2011
Nuclear Factor-κB Activation as a Pathological Mechanism of Lipid Metabolism and Atherosclerosis
2015
Tumor Exosomal RNAs Promote Lung Pre-metastatic Niche Formation by Activating Alveolar Epithelial TLR3 to Recruit Neutrophils
2016
Integrins in cancer: biological implications and therapeutic opportunities
2009 Standout
'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage
2007
Combination cancer immunotherapy and new immunomodulatory targets
2015
Nucleotide signalling during inflammation
2014 StandoutNature
Extracellular adenosine triphosphate and adenosine in cancer
2010
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
The MET receptor tyrosine kinase in invasion and metastasis
2007
Purinergic Signaling in the Airways
2012
Transforming Growth Factor-β Signaling in Immunity and Cancer
2019 Standout
Marine natural products
1990 Standout
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
Targeting adenosine for cancer immunotherapy
2018
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Purinergic regulation of the immune system
2016
Blockade of adenosine A2A receptor enhances CD8+ T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma
2017
Immunogenic cell death in cancer and infectious disease
2016 Standout
Scatter-factor and semaphorin receptors: cell signalling for invasive growth
2002
CD73: a potent suppressor of antitumor immune responses
2012
Adenosine receptors and asthma
2008
Cancer immunotherapy utilizing gene-modified T cells: From the bench to the clinic
2015
The molecular biology of head and neck cancer
2010 Standout
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
The tumor microenvironment
2020 Standout
Skeletal infections: microbial pathogenesis, immunity and clinical management
2022 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Epithelial–mesenchymal transitions in tumour progression
2002 Standout
Drug development of MET inhibitors: targeting oncogene addiction and expedience
2008
The A3 adenosine receptor: An enigmatic player in cell biology
2007
Cancer as an overhealing wound: an old hypothesis revisited
2008 Standout
Adenosine signalling in airways
2006
Inflammasome: Cancer's friend or foe?
2014
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
B cell regulation in cancer and anti-tumor immunity
2017
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
2016 Standout
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
2008 Standout
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
Dendritic cells tolerized with adenosine A2AR agonist attenuate acute kidney injury
2012
Targeting ferroptosis as a vulnerability in cancer
2022 Standout
Big opportunities for small molecules in immuno-oncology
2015
Ligand-Independent Adenosine A2B Receptor Constitutive Activity as a Promoter of Prostate Cancer Cell Proliferation
2016
Hepatocyte growth factor/scatter factor in development, inflammation and carcinogenesis: its expression and role in oral tissues
2003
Adenosine receptors as drug targets — what are the challenges?
2013
HGF and ligation of αvβ5 integrin induce a novel, cancer cell-specific gene expression required for cell scattering
2003
The PI3K Pathway in Human Disease
2017 Standout
Cancer-related inflammation and treatment effectiveness
2014 Standout
Immunity, inflammation and cancer: a leading role for adenosine
2013
Alpharetroviral self-inactivating vectors produced by a superinfection-resistant stable packaging cell line allow genetic modification of primary human T lymphocytes
2016 StandoutNobel
The acute respiratory distress syndrome
2012 Standout
Targeting immune cells for cancer therapy
2019
A2aR antagonists: Next generation checkpoint blockade for cancer immunotherapy
2015
B cells, plasma cells and antibody repertoires in the tumour microenvironment
2020
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
2009 Standout
Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells
2012
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
2018 Standout
A 2B Adenosine Receptors Induce IL-19 from Bronchial Epithelial Cells, Resulting in TNF-α Increase
2006
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Structurally Enabled Discovery of Adenosine A2A Receptor Antagonists
2016
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility
2008
CD73: A potential biomarker for anti-PD-1 therapy
2015
Cancer Immunotherapy: Selected Targets and Small‐Molecule Modulators
2016
Immunometabolism governs dendritic cell and macrophage function
2015 Standout
Activated HGF-c-Met Axis in Head and Neck Cancer
2017
Tumor microenvironment converts plasmacytoid dendritic cells into immunosuppressive/tolerogenic cells: insight into the molecular mechanisms
2012
Control of immune cell entry through the tumour vasculature: a missing link in optimising melanoma immunotherapy?
2017
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
ICOS+Foxp3+TILs in gastric cancer are prognostic markers and effector regulatory T cells associated withHelicobacter pylori
2016 StandoutNobel
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
The Met pathway: master switch and drug target in cancer progression
2006
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
2019 Standout
Regulatory B cells in anti-tumor immunity
2015
Transcriptional regulation of myeloid-derived suppressor cells
2015
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Blockade of A 2A receptors potently suppresses the metastasis of CD73 + tumors
2013
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
The ectonucleotidases CD 39 and CD 73: Novel checkpoint inhibitor targets
2017
Staphylococcal Osteomyelitis: Disease Progression, Treatment Challenges, and Future Directions
2018
2,5-Diketopiperazines: Synthesis, Reactions, Medicinal Chemistry, and Bioactive Natural Products
2012
The B-Side of Cancer Immunity: The Underrated Tune
2019
Satellite Cells and the Muscle Stem Cell Niche
2013 Standout
A Metabolic Immune Checkpoint: Adenosine in Tumor Microenvironment
2016
Role of plasmacytoid dendritic cells and inducible costimulator‐positive regulatory T cells in the immunosuppression microenvironment of gastric cancer
2013
Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
2017 StandoutNobel
Protease-Activated Receptors: Contribution to Physiology and Disease
2004
Proteinase-Activated Receptors: Transducers of Proteinase-Mediated Signaling in Inflammation and Immune Response
2004
Physiology of Microglia
2011 Standout
Immunogenic Cell Death in Cancer Therapy
2012 Standout
Works of Silvana Morello being referenced
A protective role for proteinase activated receptor 2 in airways of lipopolysaccharide-treated rats
2005
Cl-IB-MECA inhibits human thyroid cancer cell proliferation independently of A3 adenosine receptor activation
2008
The activation of liver X receptors inhibits toll‐like receptor‐9‐induced foam cell formation
2010
NK1.1+ Cells and CD8+ T Cells Mediate the Antitumor Activity of Cl-IB-MECA in a Mouse Melanoma Model
2011
Role of Plasmacytoid Dendritic Cells in Lung-Associated Inflammation
2010
MET receptor is overexpressed but not mutated in oral squamous cell carcinomas
2001
Adoptive Immunotherapy with Cl-IB-MECA-Treated CD8+ T Cells Reduces Melanoma Growth in Mice
2012
Lung cancer and Toll-like receptors
2011
Cl‐IB‐MECA enhances TRAIL‐induced apoptosis via the modulation of NF‐κB signalling pathway in thyroid cancer cells
2009
Blockade of A2b Adenosine Receptor Reduces Tumor Growth and Immune Suppression Mediated by Myeloid-Derived Suppressor Cells in a Mouse Model of Melanoma
2013
Myeloid cells in the tumor microenvironment: Role of adenosine
2015
Targeting the adenosine A2b receptor in the tumor microenvironment overcomes local immunosuppression by myeloid-derived suppressor cells
2014
Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab
2017
The adenosinergic system in cancer
2013
Alteration of Adenosine Receptors in Patients with Chronic Obstructive Pulmonary Disease
2005
B Cells Contribute to the Antitumor Activity of CpG-Oligodeoxynucleotide in a Mouse Model of Metastatic Lung Carcinoma
2011
Pharmacological dissection of vascular effects caused by activation of protease‐activated receptor 1 and 2 in anesthetized rats
2001
Polyinosinic-Polycytidylic Acid Limits Tumor Outgrowth in a Mouse Model of Metastatic Lung Cancer
2012
Design and expression of peptides with antimicrobial activity againstSalmonellatyphimurium
2016
IL-1β and TNF-α Regulation of the Adenosine Receptor (A2A) Expression: Differential Requirement for NF-κB Binding to the Proximal Promoter
2006
Adenosine limits the therapeutic effectiveness of anti-CTLA4 mAb in a mouse melanoma model.
2014
Inhibition of CD73 Improves B Cell-Mediated Anti-Tumor Immunity in a Mouse Model of Melanoma
2012
Myeloid-derived suppressor cells contribute to A2B adenosine receptor-induced VEGF production and angiogenesis in a mouse melanoma model
2015
Plasmacytoid Dendritic Cells Alter the Antitumor Activity of CpG-Oligodeoxynucleotides in a Mouse Model of Lung Carcinoma
2010
Spiro[(dihydropyrazin-2,5-dione)-6,3′-(2′,3′-dihydrothieno[2,3-b]naphtho-4′,9′-dione)]-Based Cytotoxic Agents: Structure–Activity Relationship Studies on the Substituent at N4-Position of the Diketopiperazine Domain
2008